About Longdom Conferences
Longdom conferences hosting 200+ leading international conferences and virtual events annually and is instrumental in bringing together experts and learners from all over the globe for mutual growth and effective research-oriented discussions. As per the present market demand and growth in the field of Clinical Oncology and Haematology, A Longdom Conference is hosting its “4th International Conference on Clinical Oncology and Haematology”, which is scheduled for October 19-20, 2022 in the Paris, France. The field of Clinical Oncology and Haematology which are continuously evolving and have placed many landmarks in different research and development sectors such as, Oncology, healthcare, drug discovery, Chemotherapy and many other industrial areas. The World's Leading Oncology Conference Clinical Oncology 2022 extends immense pleasure in inviting you to join us at this conference which will be focusing on the theme “Interchange The Science Enlightment about the Cancer Research” to engage, empower, evolve, and explore knowledge among attendees. This conference will be focussing on the core knowledge and major advances in the rapidly emerging fields of Clinical Oncology and Therapeutics by attracting eminent scholars, experts, and professionals globally.
Why join LONGDOM conferences?
Understand the current state of research | Meet international colleagues and experts | Visit the exhibition of leading-edge technology | Engage with editors of the top journals in your field | Global networking and certification | Brand Launching and many more to explore.
Who will be the participants?
Academic Deans and Directors | Professors and project leads | Post docs and research scholars | Young scientists and students | CEOs/ CFOs/ Chairs/ Vice-Chairs | Marketing/ business and development teams | Experts who are keen-sighted for collaboration | Product designers and resolution workers | Business sales & services professionals | Associations and society members | Funding organizations & fund raisers.
"The primary aim of this global conference is to provide a right stage to all the attendees to form research centred partnership in addressing the challenges and translational research from academia to industry. All these opportunities will support professional growth of younger scientists, which will promote future associations and improve contribution and input to their exciting research work"
Important Scientific Sessions
Track 1: Cancer Stem Cells and Biomarkers
Cancer stem cells (CSCs) are cancer cells found within tumours or haematological cancers that have characteristics similar to normal stem cells, namely the ability to give rise to all cell types found in a specific cancer sample. CSCs are thus tumorigenic (tumorigenic), possibly in contrast to other non-tumorigenic cancer cells. Through the stem cell processes of self-renewal and differentiation into multiple cell types, CSCs can generate tumours. Such cells are thought to persist as a distinct population in tumours, causing relapse and metastasis by giving rise to new tumours. A biomarker is defined as "a biological molecule found in blood, other bodily fluids, or a tissue that indicates a normal or abnormal process, or a condition or disease, such as cancer." A variety of factors can cause the changes, including germline or somatic mutations, transcriptional changes, and posttranslational modifications.
Best Oncology Societies
American Cancer Society | European Society for Medical Oncology | American Association for Cancer Research (AACR) | American Society of Clinical Oncology | Leukaemia & Lymphoma Society | International Gynaecologic Cancer Society | The National Children's Cancer Society | Oncology Nursing Society | Canadian Cancer Society
Best Oncology Conferences
Cancer Stemcells and Biomarker Conferences | Biomarker meetings | Cancer Stemcell Symposiums | Biomarker Symposiums | Upcoming Conferences of Cancer Stemcells | Upcoming Conferences on Biomarkers | Top Cancer Stemcell Conferences | Top Biomarker Conferences | Cancer Stemcell Meetings | Biomarker Meetings | Intenational Conference on Cancer Stemcells and Biomarkers | Upcoming International Conference on Stemcells and Biomarkers
Track 2: Organ-Specific Cancer
Cancer is a group of diseases characterised by abnormal cell growth with the potential to invade or spread to other parts of the body. Not all lumps or tumours are cancerous; benign tumours are not considered cancer because they do not spread to other parts of the body. Human cancers are known to be over 100 different types.
Oncology Societies of Excellence
Association of Medical Research Charities , London | Cancer Aid Society | Himachal Pradesh Swasthya Bima Yojana Society | France - European Association of Nuclear Medicine | Jamaica Cancer Society | Singapore Cancer Society | Rashtriya Cancer Benefit Society |
Best Oncology Conferences
International Conferences on Organ-Specific Cancer | Upcoming International Conferences on Organ- Specific Cancer | Organ-Specific Cancer Symposiums | Organ-Specific Cancer Meetings | Upcoming Conferences On Organ- Specific Cancer | Meetings on Organ-Specific Cancer | Symposiums on Organ-Specific Cancer | Cancer Conferences | Cancer Symposiums | Cancer Meetings | Organ-Specific Cancer Meetings
Track 3: Cancer Epidemology
Cancer epidemiology is the study of the distribution and risk factors for cancer development. Cancer epidemiology can be used to identify events that increase or decrease the incidence of cancer in specific populations. Cancer epidemiology is the study of the factors that affect cancer in order to infer possible trends and causes. Cancer epidemiology is the study of the causes of cancer as well as the identification and development of better treatments.
Top Societies for Oncology
American Medical Association | Kerala Social Security Mission | Indian Society Of Colposcopy And Cervical Pathology | Association of Medical Research Charities – London | Cancer Aid Society | Himachal Pradesh Swasthya Bima Yojana Society | France - European Association of Nuclear Medicine | Jamaica Cancer Society
Top Conferences for Oncology
Cancer Epidemology Conferences | Cancer Epidemology Meetings | Cancer Epidemology Events | Cancer Epidemology Symposiums | International Conferences on Cancer Epidemology | Upcoming International Conferences on Cancer Epidemology | Meetings on Cancer Epidemology | Symposiums on Cancer Epidemology
Track 4: Cancer Screening and Diagnostics
Cancer screening tests seek to detect cancer before symptoms appear, when it may be easier to treat successfully. Screening tests assess a person's risk of developing a genetic condition. A good screening test is one that
- Early detection of cancer
- Reduces the likelihood that someone who is regularly screened will die from cancer.
- Has more potential advantages than disadvantages
The risks of screening tests include bleeding or other physical damage, false-positive or false-negative test results, and overdiagnosis (the diagnosis of cancers that would not have caused problems and did not require treatment). Blood tests, medical histories, physical examinations, and other procedures may be used to aid in the diagnosis.
Oncology Societies Directory
Singapore Cancer Society | Rashtriya Cancer Benefit Society | Indian Society of Oncology | Society of Surgical Oncology | Oncology Nursing Society | International Psycho-Oncology Society | American Psychosocial Oncology Society
Various Oncology Conferences
Conferences on Cancer Screening and Diagnostics | Cancer Screening and Diagnostic Symposiums | Cancer Screening and Diagnostic Events | Cancer Screening and Diagnostic Meetings | Upcoming International Conferences on Cancer Screening and Diagnostics | International Conferences on Cancer Screening and Diagnostics
Track 5: Targeted Cancer Therapy
Targeted medical care could be a style of cancer treatment that concentrate ons proteins that management however cancer cells grow, divide, and spread. It’s the inspiration of exactness medicine. As researchers learn a lot of regarding the deoxyribonucleic acid changes and proteins that drive cancer, they're higher ready to style treatments that target these proteins.
Similar Societies in Oncology
American Society of Hematology | ACOS - Asian Clinical Oncology Society | World Federation of Surgical Oncology Societies | Indian Society of Clinical Oncology | Paediatric Radiation Oncology Society | Jefferson Oncology Society | Clinical Oncology Society of Australia | Society of Urologic Oncology | Society for Immunotherapy of Cancer (SITC)
Similar Conferences in Oncology
Targeted Cancer Therapy Conferences | Targeted Cancer Therapy Symposiums | Targeted Cancer Therapy Meetings | Targeted Cancer Therapy Events | International Conferences On Targeted Cancer Therapy | Upcoming International Conferences On Targeted Cancer Therapy | Events on Targeted Cancer Therapy
Track 6: Anti- Cancer Drug Discoverey and Development
The development of new anticancer agents is a lengthy process that includes acquiring new compounds, screening for antitumor activity, manufacturing and formulation, animal toxicology, and finally assessing the compound's toxicity and antitumor activity in humans. In the United States, drugs go through a lengthy development and approval process. Before any drug is prescribed to a patient, researchers ensure that it is both safe and effective in treating cancer. This process can take many years and a lot of money. The time it takes to develop and approve a drug from the time a researcher has an idea varies. A new drug is developed in three stages. Preclinical research is when a drug is discovered and tested for the first time.
Supporting Oncology Societies
World Federation of Surgical Oncology Societies | Indian Society of Clinical Oncology | Paediatric Radiation Oncology Society | Jefferson Oncology Society | Clinical Oncology Society of Australia | Society of Urologic Oncology | Society for Immunotherapy of Cancer (SITC) | Society of Hematologic Oncology (SOHO) | Japan Society of Clinical Oncology | British Cardio-Oncology Society | Northern New England Clinical Oncology Society
Supporting Oncology Conferences
Conferences on Anti-Cancer Drug and Development | Upcoming International Conferences on Anti-Cancer Drug | Anti-Cancer Drug Symposiums | Anti-Cancer Drug Meetings | Events on Anti-Cancer Drug | International Conferences On Anti-Cancer Drug
Track 7: Precision Cancer Medicine and Oncology
Aiming to provide patients with individualised care, Precision Cancer Medicine is an open access, peer-reviewed online magazine that covers a variety of topics in oncology, pathology, imaging, radiotherapy, chemotherapy, surgery, anesthesiology, nursing, and other related fields. Oncology, as a scientific field, is defined as the study of tumours and cancers. Onco denotes bulk, mass, or tumour, and -logy implies study in the word.
Leading Societies in Oncology
American Cancer Society | European Society for Medical Oncology | American Association for Cancer Research (AACR) | American Society of Clinical Oncology | Leukaemia & Lymphoma Society | International Gynaecologic Cancer Society | The National Children's Cancer Society | Oncology Nursing Society | Canadian Cancer Society | the Swedish cancer society | American Society for Radiation Oncology | Indian Cancer Society
Frequently Occurring Oncology Conferences
Conferences on Precision Cancer Medicine | Upcoming International Conferences On Precision Cancer Medicine | Precision Cancer Medicine and Oncology Events | Precision Cancer Medicine Symposiums | Oncology Events | Oncology Symposiums | Meetings On Precision Cancer Medicine | Meetings on Oncology
Track 8: Paediatric Oncology
The study and treatment of cancer in children and young adults is known as paediatric oncology. Cancers that manifest in youngsters frequently differ from those that do so in adults. Tumors in children are not always treated the same as cancers in adults. A medical speciality devoted to treating children with cancer is called paediatric oncology. It's crucial to be aware that this knowledge is available and that many types of paediatric cancer can be successfully treated.
Oncology Societies of Interest
The American Society of Breast Surgeons | International Cancer Society | International Thyroid Resources and Societies | World Cancer care Charitable Society | Trinidad & Tobago Cancer Society | Canadian Association of Radiation Oncology | American Medical Association | Kerala Social Security Mission | The Cardiovascular and Interventional Radiological Society of Europe (CIRSE)
Most Relevant Oncology Conferences
Paediatric Oncology Conferences | Upcoming Paediatric Oncology Conferences | Paediatric Oncology Meetings | Paediatric Oncology Events | Symposiums on Paediatric Oncology | International Conferences on Paediatric Oncology | Upcoming International Conferences on Paediatric Oncology
Track 9: Cancer Nursing and Palliative Care
Palliative care is medical treatment designed to enhance the quality of life for people with serious or life-threatening illnesses, such cancer. Giving it with or without curative treatment is possible. A multidisciplinary team that includes doctors, nurses, registered dieticians, pharmacists, occupational therapists, physical therapists, chaplains, psychologists, and social workers may also include palliative care specialists. Together with the cancer care team, the palliative care team manages a patient's care and upholds the highest level of quality of life for them.
Core Oncology Societies
World Cancer care Charitable Society | Trinidad & Tobago Cancer Society | Canadian Association of Radiation Oncology | American Medical Association | Kerala Social Security Mission | The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) | Indian Society Of Colposcopy And Cervical Pathology | Association of Medical Research Charities – London | Cancer Aid Society | Himachal Pradesh Swasthya Bima Yojana Society
Broad Oncology Conferences
Conferences on Cancer Nursing and Palliative Care | Upcoming International Conferences on Cancer Nursing and Palliative Care | Cancer Nursing Symposiums | Cancer Nursing Events | Palliative Care Events | Symposiums on Palliative Care | Upcoming Conferences on Cancer Nursing and Palliative Care
Market Analysis Report of Clinical Oncology 2022
Report Highlights:
Molecular Diagnostics Market is anticipated to reach US$ 31.94 Bn. by 2027 from US$ 16.80 Bn. in 2020 at a CAGR of 11.3% during a forecast period. Molecular diagnostics, also known as molecular pathology, is evaluating the sequences of DNA or RNA, the unique genetic code contained in our cells, for red flags that might indicate the advent of a certain disease. The discipline has grown dramatically in recent years as a result of advancements in the pharmaceutical and healthcare industries, as well as advances in next-generation scientific sequencing.
